CVE-2007-3887

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in mesaj_formu.asp in ASP Ziyaretci Defteri 1.1 allow remote attackers to inject arbitrary web script or HTML via the (1) Isim, (2) Mesajiniz, and (3) E-posta fields. NOTE: these probably correspond to the isim, mesaj, and posta parameters to save.php.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.52%
Vendor Advisory secunia.com Vendor Advisory secunia.com Vendor Advisory vupen.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://secunia.com/advisories/26079 third party advisory vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/35445 vdb entry
http://secunia.com/advisories/26375 third party advisory vendor advisory
http://www.vupen.com/english/advisories/2007/2558 vdb entry vendor advisory
http://www.packetstormsecurity.org/0707-exploits/aspziy-xss.txt exploit
http://www.securityfocus.com/bid/24937 vdb entry

Frequently Asked Questions

What is the severity of CVE-2007-3887?
CVE-2007-3887 has been scored as a medium severity vulnerability.
How to fix CVE-2007-3887?
To fix CVE-2007-3887, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2007-3887 being actively exploited in the wild?
It is possible that CVE-2007-3887 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.